FDA Adverse Event Injury Summary report: N

XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM

MDR report key: 2131616 · Received June 16, 2011

Report

Report Number
2024168-2011-04259
Event Type
Injury
Date Received
June 16, 2011
Date of Event
January 1, 2011
Report Date
May 5, 2011
Manufacturer
AV-TEMECULA-CT
Product Code
NIQ
PMA / PMN Number
P070015
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE EVENT, PATIENT AND DEVICE INFORMATION. THERE WAS NO REPORTED PRODUCT DEFICIENCY. THE REPORTED ANGINA AND RE-STENOSIS ARE LISTED IN THE INSTRUCTIONS FOR USE AS KNOWN ADVERSE EVENTS ASSOCIATED WITH CORONARY STENTING. ALTHOUGH A CONCLUSIVE CAUSE FOR THE REPORTED PATIENT EFFECTS, AND THE RELATIONSHIP TO THE PRODUCT, IF ANY, CANNOT BE DETERMINED, THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY WITH RESPECT TO MANUFACTURING, DESIGN OR LABELING AND THE TREATMENT APPEARS TO BE RELATED TO THE OPERATIONAL CONTEXT OF THE PROCEDURE. THE OTHER TWO XIENCE V STENTS ARE BEING REPORTED UNDER SEPARATE MEDWATCH REPORT NUMBERS.

Description of Event or Problem · 1

IT WAS REPORTED THAT APPROXIMATELY 4 YEARS POST IMPLANTATION OF THREE XIENCE V STENTS IN THE DISTAL TO MID RIGHT CORONARY ARTERY (D-MRCA), THE PATIENT EXPERIENCED CHEST PAIN AND SHORTNESS OF BREATH DUE TO IN-STENT RESTENOSIS OF THE MRCA AND DRCA. ON (B)(6) 2011, THE PATIENT WAS HOSPITALIZED FOR BALLOON ANGIOPLASTY AND PLACEMENT OF A NON-ABBOTT STENT TO THE RESTENOSED STENTS. ALSO, A NEW LESION IN THE POSTERIOR DESCENDING ARTERY WAS TREATED. THERE WAS NO ADVERSE PATIENT SEQUELA AND ON 1/21/11, THE PATIENT WAS DISCHARGED. ALTHOUGH REQUESTED, THERE WAS NO ADDITIONAL INFORMATION PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM DRUG ELUTING CORONARY STENT SYSTEM NIQ AV-TEMECULA-CT 60601P1

Patients

Seq Age Sex Outcome Treatment
1 59 YR Hospitalization| R STENT: XIENCE V STENTS(X2)